COVID-19 vaccine sales push Moderna past expectations in Q2

Better-than-expected COVID-19 vaccine sales pushed Moderna past Wall Street’s second-quarter forecasts. The company said that its Spikevax vaccine brought in $4.53 billion during the quarter. Analysts were looking for around $3.6 billion, according to FactSet. Moderna shares surged Wednesday after the company also announced another $3 billion share buyback plan. Moderna’s vaccine sales in the…

Read More
U.S. Factory Orders Rise Solidly In June, Beat Expectations

U.S. Factory Orders Rise Solidly In June, Beat Expectations

WASHINGTON (Reuters) – New orders for U.S.-manufactured goods increased solidly in June and business spending on equipment was stronger than initially thought, pointing to underlying strength in manufacturing despite rising interest rates. The Commerce Department said on Wednesday that factory orders rose 2.0% in June after advancing 1.8% in May. Economists polled by Reuters had…

Read More

Dolly Parton among Carnegie Medal of Philanthropy winners

NEW YORK (AP) — Country superstar Dolly Parton, who made a big donation to help fund coronavirus vaccine research in 2020, is among this year’s Carnegie Medal of Philanthropy recipients. Also being honored are Dallas entrepreneur Lyda Hill, Kenyan industrialist Manu Chandaria, and Lynn and Stacy Schusterman, from the Oklahoma investment family. The award, presented…

Read More

Growing prescriptions help push CVS past Q2 expectations

CVS Health thumped second-quarter expectations and hiked its full-year forecast as growing prescription claims and COVID-19 test kits sales countered a drop in vaccinations. A longer cough, cold and flu season also brought in more business, and claims in CVS Health’s biggest segment, pharmacy benefits management, rose about 4%. Pharmacy sales at the company’s established…

Read More